Skip to main content

Table 1 Demographic and clinical characteristics of the conventional therapy and the FCSEMS groups

From: Fully covered self-expandable metal stent for intraprocedural or late-diagnosed Type-II endoscopic retrograde cholangiopancreatography-related perforations

 

Conventional (n = 9)

FCSEMS (n = 19)

P

Age (y)

68 (60–77)

70 (33–88)

0.522

Sex (Male/Female)

5/4

8/11

0.505

ERCP İndication- choledocolithiasis

7 (77.8%)

16 (84.2%)

0.454

Malignancy

2 (22.2%)

1 (5.3%)

0.175

Abnormal papilla anatomy

2 (22.2%)

3 (15.5%)

0.678

 Atypical papilla position

2

1

 

 Near the diverticulum

0

2

 

Previous ERCP history

2 (22.2%)

6 (31.6%)

0.484

Previous surgery history

5 (55.6%)

10 (52.6%)

0.885

 Distal gastrectomy and Bilroth II reconstruction

2

0

 

 Cholecystectomy

3

10

 

Precut sphincterotomy

1 (11.1%)

6 (31.6%)

0.243

Pancreatitis

2 (22.2%)

5 (26.3%)

0.815

  1. ERCP, Endoscopic retrograde cholangiopancreatography, FCSEMS, Fully covered self-expandable metal stent, Abnormal papilla anatomy, periampullary diverticulum or atypical papilla position